Investigation and potential lawsuits against Bayer for its drug Baycol.
Baycol is designed to aid patients in lowering cholesterol. According to the Food and Drug Administration ('FDA'), Bayer voluntarily removed Baycol from the US market because of reports of sometimes fatal rhabdomyolysis, a severe muscle adverse reaction from this anti-cholesterol product. The FDA reported at least 31 deaths due to severe rhabdomyolysis associated with use of Baycol.
Rhabdomyolysis is a condition that results in muscle cell breakdown and release of the contents of muscle cells into the bloodstream. Symptoms of rhabdomyolysis include muscle pain, weakness, tenderness, malaise, fever, dark urine, nausea, and vomiting. The pain may involve specific groups of muscles or may be generalized throughout the body.
Do not change medications without first consulting your doctor.
Name (Stock Symbol)
Bayer AG manufactures pharmaceuticals and consumer products.
The information provided on ClassAdvocate.com is general in nature,
does not apply to any particular factual situation, and is not and
should not be taken as legal or other professional advice. We make no
commitment or warranty that the factual, legal or any other information
on ClassAdvocate.com, or on any linked website, is accurate, complete,
error-free, or current. As such, you should not rely on such information,
and should seek professional advice if and as you determine appropriate.
ClassAdvocate.com is not a lawyer referral service, and no attorney-client
or confidential relationship is or should be formed by use of the site.
The investigations listed on ClassAdvocate.com are attorney advertisements
and do not in any way constitute a referral or endorsement by ClassAdvocate.com
or any approved or authorized lawyer referral service.